Brief: BioArctic Q1 Operating Profit SEK 210.8 Million
20/05/2026 06:01
May 20 (Reuters) - BioArctic Q1 revenue SEK 437.6 million. Q1 adjusted EPS SEK 2.4 Q1 adjusted free cash flow SEK -166 million Q1 net income SEK 212.4 million
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln